
    
      A longitudinal study will be conducted to evaluate the impact of praziquantel for the
      treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in
      Central Sudan. A cohort of schoolchildren (6-15 years of age) was investigated before and 1
      year after treatment with a single dose of praziquantel 40mg/kg.
    
  